Brokerages expect American Well Co. (NYSE:AMWL – Get Rating) to report ($0.26) earnings per share for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for American Well’s earnings, with the highest EPS estimate coming in at ($0.23) and the lowest estimate coming in at ($0.28). American Well posted earnings per share of ($0.15) in the same quarter last year, which indicates a negative year-over-year growth rate of 73.3%. The company is expected to issue its next earnings report on Monday, January 1st.
On average, analysts expect that American Well will report full year earnings of ($0.98) per share for the current fiscal year, with EPS estimates ranging from ($1.03) to ($0.88). For the next fiscal year, analysts forecast that the business will post earnings of ($0.69) per share, with EPS estimates ranging from ($0.77) to ($0.63). Zacks’ earnings per share calculations are a mean average based on a survey of analysts that cover American Well.
American Well (NYSE:AMWL – Get Rating) last released its quarterly earnings results on Monday, May 9th. The company reported ($0.26) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.22) by ($0.04). The firm had revenue of $64.20 million for the quarter, compared to the consensus estimate of $64.94 million. American Well had a negative net margin of 79.91% and a negative return on equity of 16.72%. The company’s revenue for the quarter was up 11.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($0.16) earnings per share.
In other news, CEO Ido Schoenberg sold 136,611 shares of the stock in a transaction on Monday, March 21st. The stock was sold at an average price of $3.77, for a total transaction of $515,023.47. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Phyllis Gotlib sold 16,926 shares of the firm’s stock in a transaction dated Monday, April 18th. The shares were sold at an average price of $3.58, for a total value of $60,595.08. Following the sale, the insider now directly owns 523,035 shares in the company, valued at approximately $1,872,465.30. The disclosure for this sale can be found here. Insiders sold a total of 321,047 shares of company stock worth $1,197,231 in the last ninety days. 14.68% of the stock is currently owned by corporate insiders.
Several institutional investors have recently modified their holdings of AMWL. Gagnon Securities LLC acquired a new position in American Well during the fourth quarter worth about $62,000. Gagnon Advisors LLC acquired a new stake in American Well during the 4th quarter worth $64,000. Point72 Hong Kong Ltd boosted its stake in American Well by 175.1% during the 1st quarter. Point72 Hong Kong Ltd now owns 8,087 shares of the company’s stock worth $34,000 after purchasing an additional 5,147 shares during the period. Nisa Investment Advisors LLC boosted its stake in American Well by 440.0% during the 1st quarter. Nisa Investment Advisors LLC now owns 8,100 shares of the company’s stock worth $34,000 after purchasing an additional 6,600 shares during the period. Finally, Vigilant Capital Management LLC acquired a new stake in shares of American Well in the 1st quarter worth $42,000. 43.75% of the stock is owned by hedge funds and other institutional investors.
Shares of American Well stock traded up $0.08 during trading hours on Friday, reaching $3.18. 41,505 shares of the stock traded hands, compared to its average volume of 2,995,806. The company has a 50 day moving average price of $3.55 and a 200 day moving average price of $4.74. The firm has a market capitalization of $837.34 million, a price-to-earnings ratio of -3.92 and a beta of 0.86. American Well has a one year low of $2.52 and a one year high of $14.76.
About American Well (Get Rating)
American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings. Its application offers urgent care; pediatrics; therapy; menopause nutrition; end-stage renal disease and dialysis; dermatology care; behavioral health therapy; and musculoskeletal care.
- Get a free copy of the StockNews.com research report on American Well (AMWL)
- Institutions Ring The Register On Toll Brothers Stock
- Agilent Technologies Is Bottoming But Don’t Buy It Yet
- Dick’s Sporting Goods Falls Flat On Weak Guidance
- Investors Can Get 5%-Plus Dividend Yields on These 3 Buys
- Two Retailers, One To Buy And One To Avoid
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for American Well Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Well and related companies with MarketBeat.com's FREE daily email newsletter.